Integrating breast cancer genomics and proteomics

Genetic and clinical factors best for predicting late recurrence in oestrogen receptor positive breast cancer

Breast cancer heterogeneity no barrier to predictive testing

Single cell sequencing techniques in early and late breast cancer

Multitarget FISH testing in lung cancer

Next generation sequencing in oncology

Opportunities and complications of PET CT

Early effect of PI3K-Akt-mTOR blockade on in vitro 18F-FDG uptake in HER2 breast cancer resistant to trastuzumab

Genetic alterations in postmenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer

Gene expression test distinguishes between breast cancer patients at high or low risk of late recurrence

Closing the cancer divide: Implementing the diagonal approach

Racial disparities in cancer outcomes